Metaiodobenzylguanidine scintigraphy in pulmonary and cardiac disease

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 5, 2010, Pages 511-515

  Van Kroonenburgh, Marinus ^a   Mostard, Remy ^a,b   Vöö, Stefan ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

Author keywords

metaiodobenzylguanidine; neuropathy; norepinephrine; single photon emission computed tomography and PET computed tomography

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; NEUROTRANSMITTER; NORADRENALIN;

ANGIOGENESIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; ENDOTHELIUM CELL; HEART DISEASE; HUMAN; INFLAMMATION; INNERVATION; LUNG DISEASE; LUNG SARCOIDOSIS; NERVE CELL LESION; NONHUMAN; NORADRENALIN RELEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PULMONARY HYPERTENSION; REVIEW; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR;

3-IODOBENZYLGUANIDINE; HEART DISEASES; HUMANS; LUNG DISEASES; NEURONS; POSITRON-EMISSION TOMOGRAPHY; RADIONUCLIDE IMAGING; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77955282300     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32833b1e1f     Document Type: Review

References (43)

1. Sisson JC, Wieland DM, Sherman P, et al. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 1987; 28:1620-1624. (Pubitemid 17158138)
2. Nakayo M, Shimabukuro K, Miyaji N, et al. Rapid clearance of iodine-131 MIBG from the heart and liver in patients with adrenergic dysfunction and pheochromocytoma. J Nucl Med 1985; 26:357-365.
3. Sole MJ, Drobac M, Schwartz L, et al. The extraction of circulating catecholamines by the lungs in normal man and in patients with pulmonary hypertension. Circulation 1979; 60:160-163.
4. Fillenz M. Innervation of pulmonary and bronchial blood vessels. J Anat 1970; 106:449-461.
5. Lincoln J, Burnstock G. An introduction to current research. In: Warren J, editor. The Endothelium. New York: Wiley-Liss, Inc.; 1990. pp. 21-32.
6. Miller VM. Interactions between neural and endothelial mechanisms in control of vascular tone. NIPS 1991; 6:60-63.
7. Junod AF. 5-Hydroxytryptamine and other amines in the lungs. In: Fishman AP, Fisher AB, editors. Handbook of physiology. The respiratory system 1. Bethesda: American Physiology Society; 1985. pp. 337-349.
8. Slosman DO, Polla BS, Donath A. 123I-MIBG pulmonary removal: a biochemical marker of minimal lung endothelial cell lesions. Eur J Nucl Med 1990; 16:633-637.
9. Sakamaki F, Satoh T, Nagaya N, et al. Abnormality of left ventricular sympathetic nervous function assessed by 123I-metaiodobenzylguanidine imaging in patients with COPD. Chest 1999; 116:1575-1580.
10. Mark AL. Sympathetic dysregulation in heart failure mechanisms and therapy. Clin Cardiol 1995; 18:13-18.
11. Arao T, Takabatake N, Sata M, et al. In vivo evidence of endothelial injury in chronic obstructive pulmonary disease by lung scintigraphic assessment of 123I-metaiodobenzylguanidine. J Nucl Med 2003; 44:1747-1754.
12. Takabatake N, Arao T, Sata M, et al. Involvement of pulmonary endothelial cell injury in the pathogenesis of pulmonary fibrosis: clinical assessment by 123I-MIBG lung scintigraphy. Eur J Nucl Med Mol Imaging 2005; 32:221-228.
13. Yoshiike F, Koizumi T, Urushihata K, et al. Reduced lung uptake of iodine-123 metaiodobenzylguanidine in patients with myeloperoxidase antineutrophil cytoplasmic antibodies-positive vasculitis. Respiration 2006; 73:191-196.
14. Kotzumi T, Kubo K, Hanaoka M, et al. Serial scintigraphic assessment of iodine-123 metaiodobenzylguanidine lung uptake in a patient with high altitude pulmonary edema. Chest 1999; 116:1129-1131.
15. Urushihata K, Koizumi T, Hanaoka M, et al. Reduced lung uptake of iodine-123 metaiodobenzylguanidine in high-altitude pulmonary oedema. Respirology 2008; 13:897-902.
16. Richalet JP, Merlet P, Boutgignon M, et al. MIBG scintigraphic assessment of cardiac adrenergic activity in response to altitude hypoxia. J Nucl Med 1990; 31:34-37.
17. Suga K, Kume N, Shimizu K, et al. Potential of iodine-123 metaiodobenzylguanidine single-photon emission tomography to detect abnormal functional status of the pulmonary neuroadrenergic system in irradiated lung. Eur J Nucl Med 1999; 26:647-654.
18. ÜnlüM, I?nanir S. Prolonged lung retention of iodine-123-MIBG in diabetic patients. J Nucl Med 1998; 39:116-118.
19. Murashima S, Takeda K, Matsumura K, et al. Increased lung uptake of iodine-123-MIBG in diabetics with sympathetic nervous dysfunction. J Nucl Med 1998; 39:334-338.
20. Ünlü M, Akinciog lu C, Yamaç K, Önder M. Pulmonary involvement in Behçets disease: evaluation of I123-MIBG retention. Nucl Med Comm 2001; 22:1083-1088.
21. Mu X, Hasegawa S, Yoshioka J, et al. Clinical value of lung uptake of iodine-123 metaiodobenzylguanidine (MIBG), a myocardial sympathetic nerve imaging agent, in patients with chronic failure. Ann Nucl Med 2001; 15:411-416.
22. Veith R.C. Featherstone J.A. Linares O.A. Halter J.R. Age differences in plasma norepinephrine kinetics in humans J Gerontol 1986 41 319-324
23. Veith RC, Featherstone JA, Linares OA, Halter JR. Age differences in plasma norepinephrine kinetics in humans. J Gerontol 1986; 41:319-324. 23 Kanzaki N, Soda R, Takahashi K, et al. Influence of age and gender on iodine-123 MIBG kinetics in normal lung. Ann Nucl Med 1998; 12:225-229.
24. Nicholas TE, Strum JM, Angelo LS, Junod AF. Site and mechanism of uptake of 3H-1-norepinephrine by isolated perfused rat lungs. Circ Res 1974; 35:670.
25. Sole MJ, Hussain MN. A simple specific radioenzymatic assay for the simultaneously measurement of pictogram quantities of norepinephrine, epinephrine and dopamine in plasma and tissues. Biochem Med 1977; 18:301.
26. Durmuş-Altun G, Altun A, Aktas RG, et al. Use of iodine-123 metaiodobenzylguanidine scintigraphy for the detection of amiodarone induced pulmonary toxicity in a rabbit model: a comparative study with technetium-99m diethyltriaminepenta acetic acid radioaerosol scintigraphy. Ann Nucl Med 2005; 19:217-224.
27. Morozumi T, Kusuoka H, Fukuchi K, et al. Myocardial iodine-123- metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med 1997; 38:49-52.
28. Lee KH, Ko BH, Paik JY, et al. Characteristics and regulation of 123I-MIBG transport in cultured pulmonary endothelial cells. J Nucl Med 2006; 47:437-442.
29. Jonker GJ, Smulders NM, van Kroonenburgh MJ, et al. Lung-uptake and-washout of MIBG in sarcoidosis. Respir Med 2008; 102:64-70.
30. Smulders NM, Bast A, van Kroonenburgh MJ, Drent M. Improvement of cardiac sympathetic nerve function in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2008; 25:140-142.
31. Imai E, Kaminaga T, Takada K, et al. Radioactive defect on I-123 MIBG myocardial SPECT imaging in a patient with cardiac sarcoidosis. Clin Nucl Med 2002; 27:729-730.
32. Matsuo S, Nakamura Y, Matsui T, et al. Detection of denervated but viable myocardium in cardiac sarcoidosis with I-123 MIBG and Tl-201 SPECT imaging. Ann Nucl Med 2001; 15:373-375.
33. Misumi I, Kimura Y, Hokamura Y, et al. Scintigraphic detection of regional disruption of the adrenergic nervous system in sarcoid heart disease. Jpn Circ J 1996; 60:774-778.
34. Hoitsma E, Marziniak M, Faber CG, et al. Small fiber neuropathy in sarcoidosis. Lancet 2002; 359:2085-2086.
35. Wichter T, Matheja P, Eckardt L, et al. Myocardial iodine-123- metaiodobenzylguanidine( 123I-MIBG) imaging in Brugada syndrome. Circulation 2002; 106:59-60.
36. Tuck RR, McLeod JG. Autonomic dysfunction in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1981; 44:983-990.
37. Ewing DJ, Campbell IW, Clarke BF. Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Ann Intern Med 1980; 92:308-311.
38. Ewing DJ, Boland O, Neilson JM, et al. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia 1991; 34:182-185.
39. Hoitsma E, Faber CG, van Kroonenburgh MJ, et al. Association of small fiber neuropathy with cardiac sympathetic dysfunction in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22:43-50. (Pubitemid 40444733)
40. Akutsu Y, Kaneko K, Kodamo Y, et al. The significance of cardiac sympathetic nervous system abnormality in the long-term prognosis of patients with a history of ventricular tachyarrhythmia. J Nucl Med 2009; 50:61-67.
41. Jacobson AF, Lombard J, Banerjee G, Camici PG. 123I-MIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials. J Nucl Cardiol 2009; 16:113-121.
42. Tamaki S, Yamada T, Okuayama Y, et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction. J Am Coll Cardiol 2009; 53:426-435.
43. Bombardieri E, Aktolun C, Baum RP, et al. 131I/123I- Metaiodobenzylguanidine (MIBG) scintigraphy procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging 2003; 30:132-139.